Although financial gloom is everywhere and President Trump is triggering a rumpus with his 'America initially' approach, the UK stock exchange remains unfazed.

Despite a couple of wobbles recently - and more to come as Trump rattles international cages - both the FTSE100 and larger FTSE All-Share indices have been resistant.

Both are more than 13 per cent higher than this time last year - and near tape-record highs.

Against this background of economic uncertainty, Trump rhetoric and near-market highs, it's hard to think that any outstanding UK financial investment chances for client investors exist - so called 'healing' circumstances, where there is potential for the share price of specific business to increase like a phoenix from the ashes.

But a band of fund managers is specialising in this contrarian type of investing: buying underestimated business in the expectation that gradually the marketplace will reflect their true worth.

This undervaluation may arise from poor management resulting in service errors; a hostile financial and monetary backdrop; or wider problems in the industry in which they operate.

Rising like a phoenix: Buying undervalued business in the hope that they'll eventually skyrocket needs nerves of steel and infinite perseverance

Yet, the fund managers who purchase these shares think the 'problems' are understandable, although it might take up to five years (occasionally less) for the results to be shown in far higher share prices. Sometimes, to their dismay, the problems show unsolvable.

Max King spent 30 years in the City as an investment supervisor with the similarity J O Hambro Capital Management and Investec. He says investing for healing is high risk, needs patience, a disregard for agreement investment thinking - and nerves of steel.

He also believes it has actually become crowded out by both the expansion in low-cost passive funds which track specific stock market indices - and the appeal of growth investing, developed around the success of the big tech stocks in the US.

Yet he firmly insists that recovery investing is far from dead.

Last year, King says many UK healing stocks made investors sensational returns - including banks NatWest and Barclays (still recuperating from the 2008 global monetary crisis) and aerospace and defence huge Rolls-Royce Holdings (flourishing again after the impact of the 2020 pandemic lockdown). They produced particular returns for investors of 83, 74 and 90 per cent.

Some shares, says King, have more to offer investors as they advance from healing to growth. 'Recovery investors typically purchase too early,' he says, wiki.myamens.com 'then they get bored and sell too early.'

But more significantly, he thinks that brand-new healing chances always present themselves, even in an increasing stock market. For brave financiers who buy shares in these healing situations, stellar returns can lie at the end of the rainbow.

With that in mind, Wealth asked four leading fund managers to recognize the most engaging UK healing opportunities.

They are Ian Lance, supervisor of financial investment trust Temple Bar and Alex Wright who runs fund Fidelity Special Situations and trust Fidelity Special Values. These two supervisors welcome the healing investment thesis 100 percent.

Completing the quartet are Laura Foll, who with James Henderson runs the investment portfolio of trust Law Debenture, and Imran Sattar of financial investment trust Edinburgh.

These 2 supervisors purchase recovery stocks when the investment case is compelling, however only as part of more comprehensive portfolios.

Can you succeed betting that shares in our most significant ... Why has the FTSE 100 hit record highs? INVESTING SHOW

How to select the best (and cheapest) stocks and shares Isa and the ideal DIY investing account

' Recovery stocks remain in our DNA,' states Lance who runs the ₤ 800 million Temple Bar with Nick Purves. 'The logic is easy. A business makes a tactical error - for instance, a bad acquisition - and their share rate gets cratered. We buy the shares and after that wait for a catalyst - for example, a modification in management or organization technique - which will transform the business's fortunes.

' Part of this procedure is talking with the company. But as an investor, you need to be patient.'

Recent success stories for Temple consist of Marks & Spencer which it has owned for the previous 5 years and whose shares are up 44 per cent over the past year, 91 percent over the previous 5.

Fidelity's Wright states buying recovery shares is what he provides for a living. 'We purchase unloved business and then hold them while they ideally undergo positive change,' he explains.

' Typically, any recovery in the share cost takes in between 3 and 5 years to come through, although occasionally, as happened with insurance provider Direct Line, the recovery can come quicker.'

Last year, Direct Line's board accepted a takeover offer from rival Aviva, valuing its shares at ₤ 2.75. As an outcome, its shares increased more than 60 per cent.

Foll states healing stocks 'are typically big chauffeurs of portfolio performance'. The very best UK ones, she states, are to be discovered among underperforming mid-cap stocks with a domestic business focus.

Sattar states Edinburgh's portfolio is 'varied' and 'all weather condition' with a focus on top quality firms - it's awash with FTSE100 stocks.

So, healing stocks are just a slivver of its assets.

' For us to buy a recovery stock, it needs to be first and primary an excellent service.'

So, here are our financial investment specialists' top choices. As Lance and Wright have said, they might take a while to make good returns - and absolutely nothing is guaranteed in investing, especially if Labour continues to make a pig's ear of stimulating economic growth.

But your patience could be well rewarded for embracing 'recovery' as part of your long-lasting investment portfolio.

> Look for the stocks listed below, newest efficiency, yield and more in This is Money's share centre

WINNERS IN A POSSIBLE HOME BUILDING BOOM
Marshalls is the nation's leading supplier of building, landscaping, and roofing products - buying roofing expert Marley 3 years back.

Yet it has struggled to grow income against the backdrop of 'tough markets' - last month it said its revenue had actually fallen ₤ 52million to ₤ 619 million in 2024.

The share cost has actually gone nowhere, falling 10 and 25 percent over the past one and 2 years.

Yet, lower interest rates - a 0.25 percent cut was announced by the Ban > k of England last Thursday - and the meeting of a yearly housebuilding target of 300,000 set by Chancellor Rachel Reeves may assist spark Marshalls' share price.

Law Debenture's Foll states any pick-up in housebuilding needs to lead to a need surge for Marshalls' items, streaming through to higher profits. 'Shareholders might enjoy appealing overall returns,' she says, 'although it may take a while for them to come through.' Edinburgh's Sattar likewise likes Marshalls although, unlike Foll who already holds the company's shares in Law Debenture's portfolio, it is just on his 'radar'.

He states: 'Its sales volumes are still listed below pre-pandemic levels. If the Chancellor does her bit to re-

fire up housebuilding, then it should be a beneficiary as a supplier of materials to brand-new homes.'

Sattar likewise has an eye on home builders' merchant Travis Perkins which he has owned in the past. 'It has fresh management on board [a new chairman and president] and I have a meeting with them quickly,' he states.

' From an investment perspective, it's a choices and shovels approach to gaining from any growth in the real estate market which I choose to buying shares in private housebuilders.'

Like Marshalls, Travis Perkins' shares have actually gone nowhere, falling by 7, 33 and 50 percent over one, 2 and 3 years.

Another recipient of a possible housebuilding boom is brick producer Ibstock. 'The business has actually big repaired costs as an outcome of warming the huge kilns needed to make bricks,' says Foll.

' Any uptick in housebuilding will increase brick production and sales, having an exaggerated benefit on its operating expense.'

Lower rate of interest, she adds, should likewise be a positive for Ibstock. Although its shares are 14 percent up over the past year, they are up a meagre 0.3 percent over 2 years, and down 11 and 42 percent over three and 5 years.

Fidelity's Wright has likewise been buying shares in 2 companies which would gain from an improvement in the real estate market - kitchen supplier Howden Joinery Group and retailer DFS Furniture.

Both business, he states, forum.batman.gainedge.org are gaining from having a hard time competitors. In Howden's case, rival Magnet has actually been closing display rooms, while DFS rival SCS was purchased by Italy's Poltronesofa, which then closed numerous SCS stores for repair.

DFS, a Midas pick last month, has seen its share price rise by 17 per cent over the past year, however is still down 41 per cent over three years. Howden, a constituent of the FTSE 100, has made gains of 6 per cent over both one and three years.

Six lessons from the pandemic stock market era, bytes-the-dust.com by investing master TOM STEVENSON

FUND MANAGER WORTH MORE THAN ITS PARTS
Temple Bar's Lance does not mince his words when discussing FTSE250-listed fund manager Abdrn. 'People are right when they explain it as a rather having a hard time fund management business,' he says.

'Yet what they frequently don't understand is that it also owns an effective financial investment platform in Interactive Investor and an adviser organization that, integrated, validate its market capitalisation. In result, the marketplace is putting little worth on its fund management organization. '

Include a pension fund surplus, a big multi-million-pound stake in insurer Phoenix - and Lance says shares in Abrdn have 'fantastic healing potential'.

Temple Bar took a stake in the organization at the tail end of last year. Lance is excited by the company's brand-new management team which is intent on trimming expenses.

Over the previous one and 3 years, the shares are down 3 and 34 per cent, respectively.

OTHER RECOVERY POSSIBILITIES
Fidelity's Wright says a healing stock tends to go through 3 unique phases.

First, a company embarks on favorable change (phase one, when the shares are dirt inexpensive). Then, the stock exchange identifies that change remains in development (phase 2, reflected by a rising share cost), and lastly the cost completely shows the changes made (stage 3 - and time to think about selling).

Among those shares he keeps in the phase one container (the most interesting from a financier viewpoint) is promoting huge WPP. Wright purchased WPP last year for Special Values and Special Situations.

Over one, 2 and 3 years, its shares are respectively up by 1 percent and down by 22 and 33 percent.

'WPP's shares are low-cost due to the fact that of the challenging advertising backdrop and issues over the possible disruptive impact of expert system (AI) on its profits,' he says. 'But our analysis, based in part on talking to WPP consumers, shows that AI will not interrupt its business design.'

Other recovery stocks mentioned by our specialists include engineering huge Spirax Group. Its shares are down 21 percent over the past year, however Edinburgh's Sattar says it is a 'dazzling UK industrial company, international in reach'.

He is also a fan of bug control giant Rentokil Initial which has experienced duplicated 'missteps' over its expensive 2022 acquisition of US company Terminix.

Sattar holds both stocks in the ₤ 1.1 billion trust.